Distant melanoma causing small bowel obstruction

Abstract

INTRODUCTION

Small bowel obstructions (SBOs) are common, making up 15% of all acute surgical admissions [1]. Post-operative adhesions make up the majority of cases at 84.9%, followed by abdominal herniae in 3.3% and malignant tumours in 2.5% [2]. Small bowel malignancies only account for 5% of all gastrointestinal malignancies, of which 44% are carcinoid tumours, 33% are adenocarcinomas, 17% are stromal tumours and 8% lymphomas [3]. Carcinoid tumours have a predilection for involving the ileum, whereas adenocarcinomas usually occur in the duodenum and stromal tumours in the jejunum.

Metastatic melanoma to the small bowel is rare, but a malignant cause of SBO should be considered in cases where no previous surgeries or herniae can be identified.

CASE PRESENTATION

A 71-year-old female presented to the emergency department with constipation and obstipation for the previous 3 days. Associated with that she had nausea and vomiting.

Her past medical history included type 2 diabetes mellitus. Her surgical history was significant for a primary cutaneous melanoma excision on her right arm 9 years prior to her presentation. She had attended routine follow-up for 5 years following her melanoma surgery.

On initial examination she had clinical signs of dehydration—dry mucous membranes, oliguria, decreased skin turgor—a grossly distended abdomen, no abdominal scars or herniae and high-pitched bowel sounds.

A plain-film of the abdomen and erect chest x-ray showed multiple dilated loops of small bowel. A subsequent CT scan showed a high-grade SBO involving the proximal mid small bowel as well as a small bowel to small bowel intussusception (Fig. 1). There were also multiple mucosal-enhancing lesions in the stomach, duodenum and small bowel most consistent with metastases (Fig. 2), as well as a suspicious mass in the lung base.

Figure 1:

Coronal CT showing small bowel to small bowel intussusception (arrow).

Open in new tabDownload slide

Figure 2:

Coronal CT showing small bowel mucosal-enhancing lesion (arrow).

Open in new tabDownload slide

The patient was initially managed conservatively with wide-bore sump NG as well as intravenous hydration. She was then brought to the operating theatre and underwent a laparoscopy where multiple dilated loops of small bowel were seen and then converted to laparotomy to avoid enterotomy. The small bowel was examined where six discrete lesions of intussusception were identified (Fig. 3), distributed all along the small bowel from the DJ flexure to terminal ileum, and manually reduced (Fig. 4). This provided satisfactory relief of the obstruction. All small bowel was re-examined and was viable. The lead point for each intussusception was an intraluminal lesion in each site. Due to the extent of the intestinal disease, coupled with suspicion of further distal disease in the chest on the pre-op CT, it was decided that it would be inappropriate to perform resections. Further, resecting all lesions would have carried a considerable risk of short-bowel syndrome. One lesion was biopsied to obtain a tissue diagnosis, revealing epithelioid cells with central nuclei and prominent nucleoli with a nested growth pattern, positive for S100 (Fig. 5a) and melan A (Fig. 5b) and a diagnosis of metastatic melanoma was made. The patient recovered well following her surgery. She was discharged on post-operative Day 7 with medical oncology follow-up arranged.

Figure 3:

Intra-operative picture demonstrating one area of small bowel to small bowel intussusception.

Open in new tabDownload slide

Figure 4:

Intra-operative picture demonstrating the same area of small bowel to small bowel intussusception post manual reduction.

Open in new tabDownload slide

Figure 5:

Biopsy of intestinal lead-point for intussusception demonstrating positivity for S100 (a) and melan-A (b).

Open in new tabDownload slide

Subsequent staging CT demonstrated brain and lung metastasis. The patient was commenced on systemic chemotherapy, in addition to a low-residue diet and did not require any further intervention for bowel obstruction. She died 9 months later from metastatic disease.

DISCUSSION

Melanoma of the gastrointestinal tract (GIT) is relatively rare, with most cases occurring as metastasis from cutaneous primary lesions [4]. In one study up to 60% of all patients with melanoma had intestinal metastasis at autopsy, with the small intestine being involved in 50%, the colon in 31% and the anorectum in 25% of cases. Overall, melanoma accounts for 1–3% of all GI malignancies [5], with most of these being metastatic lesions. Only 24 cases of primary melanoma of the small bowel have been reported in the literature to date [6]. However, in up to 26% of cases of intestinal melanomas, no extra-intestinal primary lesion can be identified [7]. In such circumstances, spontaneous regression of the primary site may explain the lack of a primary melanoma. Among intestinal malignancies, metastatic melanoma is the fifth most common malignancy, however is considered to be the extra-intestinal malignancy most likely to metastasize to the GIT. The most common site is the small intestine, owing to the rich blood supply [8]. Melanomas of the GIT are usually asymptomatic in their early stages, and are often diagnosed when acute and sometimes life-threatening complications, such as obstruction, perforation or haemorrhage occur [4]. The most common presentation of small intestinal melanoma is obstruction secondary to intussusception [4]. While intussusception is the second most common cause of acute abdominal emergency in children, it only causes between 1 and 5% of all obstructions in adults. The most frequent site in adults is the small bowel, followed closely by the ileocaecal area.

Management of such cases consists mainly of surgical intervention to resolve the acute obstruction/intussusception and stabilizing the patient. In cases where metastatic disease is limited to one or a very limited number of enteric metastasis, a metastatectomy can be considered. If an R0-status cannot be achieved or there is recurrent disease, systemic therapy with immunotherapy, chemotherapy or molecular targeted therapy, such as Vemurafenib, Ipilimumab, Pembrolizumab or Imatinib, can be considered, depending on performance status and positivity for BRAF and KIT [9]. Late recurrences of melanoma, defined as a disease-free interval of at least 10 years, have been reported as occurring in 1–25% of cases [10].

SBOs are common surgical emergencies, accounting for 15% of all acute surgical admissions. In people who present with SBO without previous surgeries or obvious herniae, a malignant cause must be considered. Melanoma is the most common extra-intestinal malignancy to metastasize to the GIT and metastases can occur many years later.

ACKNOWLEDGEMENT

The authors would like to thank the patient and their family for allowing this case and images to be used in this case report.

CONFLICT OF INTEREST STATEMENT

None of the contributing authors have any conflicts of interest to disclose.

REFERENCES